125 related articles for article (PubMed ID: 38893266)
1. Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer.
Fang C; Cheung MY; Chan RC; Poon IK; Lee C; To CC; Tsang JY; Li J; Tse GM
Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893266
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
[TBL] [Abstract][Full Text] [Related]
3. CD206
Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L
J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443
[TBL] [Abstract][Full Text] [Related]
4. Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer.
Bobrie A; Massol O; Ramos J; Mollevi C; Lopez-Crapez E; Bonnefoy N; Boissière-Michot F; Jacot W
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230752
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Number Density of Tumor-Associated Macrophages by Immunohistochemistry and Semiquantitative Scoring in Invasive Breast Cancer: An Indian Study.
Bhatia JK; Malik A; Chaudhary T; Gopal A; Boruah D; Singh B
J Microsc Ultrastruct; 2023; 11(4):214-219. PubMed ID: 38213652
[TBL] [Abstract][Full Text] [Related]
7. The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.
Jääskeläinen MM; Tiainen S; Siiskonen H; Ahtiainen M; Kuopio T; Rönkä A; Kettunen T; Hämäläinen K; Rilla K; Harvima I; Mannermaa A; Auvinen P
Breast Cancer Res Treat; 2023 Sep; 201(2):183-192. PubMed ID: 37428418
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
9. A new method for predicting the prognosis of colorectal cancer patients through a combination of multiple tumor-associated macrophage markers at the invasive front.
Wang X; Yuwen TJ; Zhong Y; Li ZG; Wang XY
Heliyon; 2023 Feb; 9(2):e13211. PubMed ID: 36798759
[TBL] [Abstract][Full Text] [Related]
10. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
Medrek C; Pontén F; Jirström K; Leandersson K
BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
[TBL] [Abstract][Full Text] [Related]
11. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer.
Maisel BA; Yi M; Peck AR; Sun Y; Hooke JA; Kovatich AJ; Shriver CD; Hu H; Nevalainen MT; Tanaka T; Simone N; Wang LL; Rui H; Chervoneva I
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053472
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer.
Jeong H; Hwang I; Kang SH; Shin HC; Kwon SY
J Breast Cancer; 2019 Mar; 22(1):38-51. PubMed ID: 30941232
[TBL] [Abstract][Full Text] [Related]
13. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
Mwafy SE; El-Guindy DM
J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
[TBL] [Abstract][Full Text] [Related]
15. Antibody combinations for optimized staining of macrophages in human lung tumours.
Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.
Feng Q; Chang W; Mao Y; He G; Zheng P; Tang W; Wei Y; Ren L; Zhu D; Ji M; Tu Y; Qin X; Xu J
Clin Cancer Res; 2019 Jul; 25(13):3896-3907. PubMed ID: 30988081
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated CD163
Yoshida C; Kadota K; Yamada K; Fujimoto S; Ibuki E; Ishikawa R; Haba R; Yokomise H
Lung Cancer; 2022 May; 167():34-40. PubMed ID: 35395482
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
Allison E; Edirimanne S; Matthews J; Fuller SJ
Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
[TBL] [Abstract][Full Text] [Related]
19. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.
Ujiie H; Kadota K; Nitadori JI; Aerts JG; Woo KM; Sima CS; Travis WD; Jones DR; Krug LM; Adusumilli PS
Oncoimmunology; 2015 Jun; 4(6):e1009285. PubMed ID: 26155428
[TBL] [Abstract][Full Text] [Related]
20. Identification and Functional Analysis of EPOR
Li Y; Li M; Wei R; Wu J
J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
